Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges: Mechanistic and Therapeutic Challenges

Tissue fibrosis may occur for unknown causes or be the consequence of many pathological conditions including chronic inflammatory or infectious diseases, autoimmune disorders, graft rejection, or malignancy. On the other hand, malignant tumors have been identified in fibrotic tissues decades ago, an...

Full description

Saved in:
Bibliographic Details
:
Year of Publication:2019
Language:English
Physical Description:1 electronic resource (348 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993548125604498
ctrlnum (CKB)4100000010106258
(oapen)https://directory.doabooks.org/handle/20.500.12854/51774
(EXLCZ)994100000010106258
collection bib_alma
record_format marc
spelling Gabazza, Esteban C. auth
Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges: Mechanistic and Therapeutic Challenges
Links between Fibrogenesis and Cancer
MDPI - Multidisciplinary Digital Publishing Institute 2019
1 electronic resource (348 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Tissue fibrosis may occur for unknown causes or be the consequence of many pathological conditions including chronic inflammatory or infectious diseases, autoimmune disorders, graft rejection, or malignancy. On the other hand, malignant tumors have been identified in fibrotic tissues decades ago, and now accumulating evidence suggests that fibrotic lesions enhance the risk of cancer in several organs such as liver, lungs, and breast. Disruption of an organ parenchymal cells and of its normal structural scaffold during tissue fibrogenesis appears to induce loss of cell polarity, promoting uncontrolled cell proliferation that may eventually lead to cancer development. Many cellular and molecular abnormalities including aberrant expression of microRNAs, genetic and epigenetic alterations, evasion or delayed apoptosis, unregulated intracellular signal pathways, and dysregulation or defective intercellular communications have been proposed to explain this link between fibrogenesis and carcinogenesis. However, the precise mechanisms of this fibrosis-to-cancer transition remain unclear. This book presents a collection of reviews and original articles summarizing recent advances in understanding the molecular mechanisms of cancer development in fibrotic organs.
English
bleomycin
regeneration
antitumor efficacy
lung cancer
SOX2
leiomyosarcoma
lung cancer (LC)
nanoparticles
cytokines
hepatocellular carcinoma
metabolic reprogramming
hepatic stellate cells
angiogenesis
transforming growth factor-?
anaplastic lymphoma kinase
idiopathic pulmonary fibrosis
growth factor
pathogenesis
cancer-associated fibroblasts
fibrosis
lipopolysaccharide
DHA
lncRNA
SREBP-1
YAP
protein S
non-small cell lung cancer (NSCLC)
omega-3 fatty acid
inflammation
metastasis
clinical symptoms
miRNA
smooth muscle tumor of uncertain malignant potential
Wnt
interstitial fluid pressure
heterogeneity
hepatocytes
myometrium
tumor necrosis factor ?
tumor
tumor microenvironment
extracellular matrix
TAZ
carcinogenesis
cystic formation
pulmonary fibrosis
HBV
cytokine
genetic instability
diagnosis
EMT
crizotinib
Hippo pathway
GPR120
marker
HCV
non-alcoholic steatohepatitis
pathology
common pathways
apoptosis
type I collagen
GPR40
acute lung injury
uterine fibroid
renal injury
pathophysiology
reactive oxygen species
immunohistochemistry
SMAD
butylidenephthalide
leiomyoma
cirrhosis
Erk1/2
targeted therapy
TGF-?
mechanotransduction
therapy
breast cancer
hepatocellular carcinoma (HCC)
hepatic stellate cells (HSCs)
idiopathic pulmonary fibrosis (IPF)
cancer-associated fibroblasts (CAFs)
cancer
signal pathway
tumor stiffness
3-03921-706-2
language English
format eBook
author Gabazza, Esteban C.
spellingShingle Gabazza, Esteban C.
Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges: Mechanistic and Therapeutic Challenges
author_facet Gabazza, Esteban C.
author_variant e c g ec ecg
author_sort Gabazza, Esteban C.
title Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges: Mechanistic and Therapeutic Challenges
title_full Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges: Mechanistic and Therapeutic Challenges
title_fullStr Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges: Mechanistic and Therapeutic Challenges
title_full_unstemmed Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges: Mechanistic and Therapeutic Challenges
title_auth Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges: Mechanistic and Therapeutic Challenges
title_alt Links between Fibrogenesis and Cancer
title_new Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges: Mechanistic and Therapeutic Challenges
title_sort links between fibrogenesis and cancer: mechanistic and therapeutic challenges: mechanistic and therapeutic challenges
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2019
physical 1 electronic resource (348 p.)
isbn 3-03921-707-0
3-03921-706-2
illustrated Not Illustrated
work_keys_str_mv AT gabazzaestebanc linksbetweenfibrogenesisandcancermechanisticandtherapeuticchallengesmechanisticandtherapeuticchallenges
AT gabazzaestebanc linksbetweenfibrogenesisandcancer
status_str n
ids_txt_mv (CKB)4100000010106258
(oapen)https://directory.doabooks.org/handle/20.500.12854/51774
(EXLCZ)994100000010106258
carrierType_str_mv cr
is_hierarchy_title Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges: Mechanistic and Therapeutic Challenges
_version_ 1787551667632209920
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04899nam-a2201297z--4500</leader><controlfield tag="001">993548125604498</controlfield><controlfield tag="005">20231214133007.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2019 xx |||||o ||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-03921-707-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000010106258</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/51774</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000010106258</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gabazza, Esteban C.</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges: Mechanistic and Therapeutic Challenges</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Links between Fibrogenesis and Cancer</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (348 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Tissue fibrosis may occur for unknown causes or be the consequence of many pathological conditions including chronic inflammatory or infectious diseases, autoimmune disorders, graft rejection, or malignancy. On the other hand, malignant tumors have been identified in fibrotic tissues decades ago, and now accumulating evidence suggests that fibrotic lesions enhance the risk of cancer in several organs such as liver, lungs, and breast. Disruption of an organ parenchymal cells and of its normal structural scaffold during tissue fibrogenesis appears to induce loss of cell polarity, promoting uncontrolled cell proliferation that may eventually lead to cancer development. Many cellular and molecular abnormalities including aberrant expression of microRNAs, genetic and epigenetic alterations, evasion or delayed apoptosis, unregulated intracellular signal pathways, and dysregulation or defective intercellular communications have been proposed to explain this link between fibrogenesis and carcinogenesis. However, the precise mechanisms of this fibrosis-to-cancer transition remain unclear. This book presents a collection of reviews and original articles summarizing recent advances in understanding the molecular mechanisms of cancer development in fibrotic organs.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bleomycin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">regeneration</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antitumor efficacy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lung cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SOX2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">leiomyosarcoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lung cancer (LC)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanoparticles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cytokines</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hepatocellular carcinoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metabolic reprogramming</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hepatic stellate cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">angiogenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">transforming growth factor-?</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anaplastic lymphoma kinase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">idiopathic pulmonary fibrosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">growth factor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pathogenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer-associated fibroblasts</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fibrosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lipopolysaccharide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">DHA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lncRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SREBP-1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">YAP</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">protein S</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-small cell lung cancer (NSCLC)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">omega-3 fatty acid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inflammation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metastasis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clinical symptoms</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">miRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">smooth muscle tumor of uncertain malignant potential</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Wnt</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">interstitial fluid pressure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heterogeneity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hepatocytes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">myometrium</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor necrosis factor ?</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor microenvironment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">extracellular matrix</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TAZ</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">carcinogenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cystic formation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pulmonary fibrosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HBV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cytokine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">genetic instability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diagnosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">EMT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">crizotinib</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Hippo pathway</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">GPR120</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">marker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HCV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-alcoholic steatohepatitis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pathology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">common pathways</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">apoptosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">type I collagen</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">GPR40</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">acute lung injury</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">uterine fibroid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">renal injury</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pathophysiology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">reactive oxygen species</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunohistochemistry</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SMAD</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">butylidenephthalide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">leiomyoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cirrhosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Erk1/2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">targeted therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TGF-?</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mechanotransduction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">breast cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hepatocellular carcinoma (HCC)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hepatic stellate cells (HSCs)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">idiopathic pulmonary fibrosis (IPF)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer-associated fibroblasts (CAFs)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">signal pathway</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor stiffness</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03921-706-2</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:39:27 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2020-02-01 22:26:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338760240004498&amp;Force_direct=true</subfield><subfield code="Z">5338760240004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338760240004498</subfield></datafield></record></collection>